Breaking News Instant updates and real-time market news.

MSCC

Microsemi

$54.95

0.65 (1.20%)

, SWKS

Skyworks

$78.93

0.72 (0.92%)

08:08
11/22/16
11/22
08:08
11/22/16
08:08

Microsemi could be acquired for $70-$90 per share, says SunTrust

After press reports suggested that Microsemi (MSCC) could be acquired by Skyworks (SWKS), SunTrust analyst William Stein estimates, based on past semiconductor deals, that Microsemi could be acquired for $70-$90 per share. The analyst thinks that Infineon (IFNNY), Marvell (MRVL), and STMicroelectronics (STM) could also be interested in acquiring Microsemi. The analyst keeps a $58 price target and a Buy rating on Microsemi.

MSCC

Microsemi

$54.95

0.65 (1.20%)

SWKS

Skyworks

$78.93

0.72 (0.92%)

IFNNY

Infineon

$17.19

0.29 (1.72%)

MRVL

Marvell

$14.75

-0.05 (-0.34%)

STM

STMicroelectronics

$9.55

0.13 (1.38%)

  • 28

    Nov

  • 14

    Feb

MSCC Microsemi
$54.95

0.65 (1.20%)

11/11/16
SPHN
11/11/16
NO CHANGE
Target $36
SPHN
Overweight
Microsemi price target raised to $36 from $26 at Stephens
Stephens analyst Dana Hambly raised his price target for Microsemi to $36 from $26 after the company reported a "strong" Q3 beat with solid acquisition and organic revenue, improving margins, and a strong financial position to continue driving future growth. The analyst reiterates an Overweight rating on the shares.
11/03/16
RHCO
11/03/16
NO CHANGE
RHCO
Microsemi would be worth $60 per share in a takeover, says SunTrust
After Bloomberg reported that Microsemi (MSCC) is evaluating a potential sale of the company after receiving takeout interest from Skyworks (SWKS), SunTrust analyst William stein estimates that Microsemi would obtain a price of $60 per share in a takeover. The analyst says that Skyworks "is a sensible suitor" for Microsemi, and he continues to identify Microsemi as a top pick.
11/07/16
RBCM
11/07/16
NO CHANGE
RBCM
Microsemi price target raised to $56 from $48 at RBC Capital
After Bloomberg reported that Microsemi (MSCC) was looking to sell itself, RBC Capital analyst Mitch Steves says that Microsemi could be attractive to many potential acquirers. He names Skyworks (SWKS), Texas Instruments (TXN), Maxim (MXIM) and Broadcom (AVGO) as potential acquirers of Microsemi. However, the analyst thinks that it "may be a bit to early for a deal." Nonetheless, he raised his price target on the name to $56 from $48 and keeps a Top Pick rating on the shares.
11/08/16
DBAB
11/08/16
INITIATION
Target $60
DBAB
Buy
Microsemi initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Ross Seymore started Microsemi with a Buy rating and $60 price target. The analyst believes the stock's risk/reward remains favorable despite the rally since mid-2016 due to synergies from acquisitions and its "stable" organic growth.
SWKS Skyworks
$78.93

0.72 (0.92%)

11/21/16
OPCO
11/21/16
NO CHANGE
OPCO
Oppenheimer recommends buying Technology, Energy ahead of breakout
Oppenheimer analyst Ari Wald says that the S&P 500's bullish reversal of its eight-week downtrend is confirming the start of a year-end rally, and cyclical stocks should be owned given resuming strength in the index's long-term trend. The analyst thinks the current opportunity is to buy Technology and Energy ahead of a breakout, namely Apple (AAPL), Seagate (STX), Skyworks (SWKS), Western Digital (WDC), Apache (APA), Chevron (CVX), Halliburton (HAL), and Helmerich & Payne (HP).
11/04/16
BMUR
11/04/16
NO CHANGE
Target $85
BMUR
Buy
Skyworks price target raised to $85 from $80 at Brean Capital
Brean Capital analyst Mike Burton raised his price target on Skyworks to $85 from $80 following its "clean" beat and raise Q4 report. Burton reiterated his Buy rating on Skyworks shares, citing its above average growth profile, discounted valuation, expectations for strong demand of its products, and opportunities for gross margin improvements.
11/04/16
NEED
11/04/16
NO CHANGE
Target $84
NEED
Buy
Skyworks price target raised to $84 from $73 at Needham
Needham analyst N. Quinn Bolton raised his price target for Skyworks (SWKS) to $84 from $73 after the company reported "strong" beat and raise results in Q4. The analyst believes the company is poised to see future revenue growth as well with Apple (AAPL) nearing full digestion of excess iPhone 6S components and Skyworks' shipments ramp up to match consumption. Further, he believes this dynamic sets the company up for better than seasonal results in Q2. Bolton reiterates a Buy rating on Skyworks' shares.
IFNNY Infineon
$17.19

0.29 (1.72%)

09/12/16
BERN
09/12/16
NO CHANGE
BERN
Infineon can double earnings power by 2021, says Bernstein
Bernstein analyst Pierre Ferragu says that Infineon can double its earnings power over the next three to five years. The company is "uniquely exposed" to "semiconductor sweet spots" in the auto and industrial markets, and it should benefit from margin increases and share gains over the next several years, according to the analyst. Ferragu keeps an EUT17 and Outperform rating on the shares.
08/03/16
UBSW
08/03/16
DOWNGRADE
UBSW
Neutral
Infineon downgraded to Neutral from Buy at UBS
07/15/16
BERN
07/15/16
NO CHANGE
BERN
Infineon acquisition positive, says Bernstein
After Infineon (IFNNY) agreed to buy Cree's (CREE) Wolfspeed division ,Bernstein says the deal "appears expensive at first." However, the firm, reporting that the unit has double the growth of all of Infineon's divisions, says that the transaction will enable the company "to secure growth for decades to come in power semiconductors." It keeps an Outperform rating on the stock.
06/22/16
BERN
06/22/16
NO CHANGE
BERN
Infineon to benefit from proliferation of electric cars, says Bernstein
Bernstein says that Infineon is "ideally positioned" to benefit from the increasing popularity of electric cars. The firm explains that electric cars need multiple times more semiconductors than traditional vehicles.. It says that Infineon's low production cost and technology advantages make it "ideally positioned" to exploit this trend. The firm keeps an Outperform rating on the shares.
MRVL Marvell
$14.75

-0.05 (-0.34%)

11/18/16
SUSQ
11/18/16
UPGRADE
Target $17
SUSQ
Positive
Marvell upgraded to Positive at Susquehanna
As reported previously, Susquehanna analyst Christopher Rolland upgraded Marvell to Positive form Neutral. In a previous note, the analyst called Marvell his top takeout candidate. Rolland feels the company could make a few adjustments to its business to unlock additional earnings power and now sees a $17 takeout price as achievable.
11/18/16
SUSQ
11/18/16
UPGRADE
SUSQ
Positive
Marvell upgraded to Positive from Neutral at Susquehanna
11/03/16
BMUR
11/03/16
NO CHANGE
Target $16
BMUR
Buy
Marvell operating expense cuts impressive, says Brean Capital
Brean Capital analyst Mike Burton said he is impressed with Marvell's follow through on its plans to drive returns to patient shareholders by cutting operating expenses. The analyst added the stock to the firm's top pick list as he believes they are a good "special situation" for investors as the company re-aligns its margin profile. Burton reiterated his Buy rating and raised his price target to $16 from $15 on Marvell shares.
10/28/16
CHLM
10/28/16
NO CHANGE
CHLM
Logical buyers of Marvell are Skyworks,Texas Instruments, says Craig-Hallum
Craig Hallum analyst Christian Schwab commented on reports that Marvell (MRVL) is close to hiring Goldman Sachs after rebuffing China bids. Excluding Qualcomm (QCOM) after its purchase of NXP Semiconductors (NXPI) and Lenovo and HiSilicon as Chinese buyers, Schwab said this leaves Skyworks (SWKS) and Texas Instruments (TXN) on his list as logical buyers of Marvell. He believes shares could fetch north of $20 in a takeout, above his $17.50 price target. The analyst has a Buy rating on Marvell shares.
STM STMicroelectronics
$9.55

0.13 (1.38%)

09/02/16
BOFA
09/02/16
DOWNGRADE
BOFA
Underperform
STMicroelectronics downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill downgraded STMicroelectronics to Underperform saying structural pressures will drive declining revenue from Q3 of 2017 and beyond.
09/02/16
09/02/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Carnival (CCL) downgraded to Underweight from Equal Weight at Morgan Stanley by analyst Jamie Rollo after the firm's checks indicated cruise demand weakened and prices were soft in August. The analyst lowered Carnival's price target to $48 from $54. 2. lululemon (LULU) downgraded to Equal Weight from Overweight by Morgan Stanley analyst Kimberly Greenberger following the company's earnings report. She noted that the company's comps are decelerating and that traffic remains a headwind. Given the slowdown seen in Q2, Greenberger lowered her comp assumptions and cut her price target on lululemon shares to $70 from $74. 3. Morgan Stanley analyst Meta Marshall downgraded Ciena (CIEN) to Equal Weight from Overweight, saying that while the company can likely outgrow the market over the next couple of years, its industry remains intensely competitive and growth is slowing in the long haul market, leaving little room for multiple expansion. Marshall maintains a $23 price target on Ciena shares. 4. Smith & Wesson (SWHC) downgraded to Hold from Buy at Craig-Hallum by analyst Steven Dyer, as he thinks the current environment is "as good as it gets" for firearms demand. Based on past cycles, Dyer contends that November's election and activity right after that will likely mark the top of the current firearms cycle and the stock will react as comps become more difficult. 5. STMicroelectronics (STM) downgraded to Underperform from Neutral at BofA/Merrill, with the firm saying structural pressures will drive declining revenue from Q3 of 2017 and beyond. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/24/16
JPMS
06/24/16
NO CHANGE
JPMS
ARM Holdings can see positive impact from sterling move, says JPMorgan
JPMorgan's European Technology analyst Sandeep Deshpande said the main impacts of the Brexit vote are currency impacts, possible tariffs and economic impacts, but noted that economic impacts are still hard to call at this point and that tariffs are likely to be less important for tech companies. Among the European tech companies he discusses, Deshpande noted that ARM Holdings (ARMH) will see a positive 1.5% impact to EPS for every 1% move in sterling. The analyst added that he does not expect ASML (ASML) to see any reportable impact from currency shifts and called out STMicroelectronics (STM) as having the greatest currency exposure among semiconductor names.
10/27/16
STFL
10/27/16
UPGRADE
STFL
Buy
STMicroelectronics upgraded to Buy from Hold at Stifel

TODAY'S FREE FLY STORIES

WMT

Wal-Mart

$70.88

0.21 (0.30%)

18:17
12/02/16
12/02
18:17
12/02/16
18:17
Periodicals
Wal-Mart to pay $7.5M to settle same-sex spouse benefit case, Reuters reports »

Wal-Mart said it would…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

18:14
12/02/16
12/02
18:14
12/02/16
18:14
Hot Stocks
S&P announces changes to S&P MidCap 400, S&P SmallCap 600 indices »

S&P Dow Jones Indices…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

, ALIOF

Actelion

$206.01

15.21 (7.97%)

18:11
12/02/16
12/02
18:11
12/02/16
18:11
Periodicals
Johnson & Johnson said to raise offer for Actelion above $250, Bloomberg says »

Johnson &…

JNJ

Johnson & Johnson

$111.96

0.58 (0.52%)

ALIOF

Actelion

$206.01

15.21 (7.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$79.10

0.3 (0.38%)

18:00
12/02/16
12/02
18:00
12/02/16
18:00
Hot Stocks
Celanese to raise list, off-list selling prices for paraformaldehyde »

Celanese Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, GMED

Globus Medical

$21.89

0.12 (0.55%)

17:56
12/02/16
12/02
17:56
12/02/16
17:56
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: HomeStreet…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

GMED

Globus Medical

$21.89

0.12 (0.55%)

BGS

B&G Foods

$42.50

0.2 (0.47%)

ZEN

Zendesk

$21.17

0.34 (1.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Jan

ZEN

Zendesk

$21.17

0.34 (1.63%)

17:53
12/02/16
12/02
17:53
12/02/16
17:53
Hot Stocks
Zendesk says SVPs Amanda Kleha and Marcus Bragg to resign »

On November 29, Amanda…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:42
12/02/16
12/02
17:42
12/02/16
17:42
Periodicals
President Obama blocks China's Fujian from acquiring Aixtron, CNBC reports »

President Barack Obama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CX

CEMEX

$7.83

0.09 (1.16%)

17:31
12/02/16
12/02
17:31
12/02/16
17:31
Hot Stocks
CEMEX to divest ready-mix concrete pumping assets in Mexico »

CEMEX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$5.15

-0.1 (-1.90%)

17:30
12/02/16
12/02
17:30
12/02/16
17:30
Syndicate
Breaking Syndicate news story on Sorrento Therapeutics »

Sorrento files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

MBRX

Moleculin Biotech

$2.63

-0.14 (-5.05%)

17:29
12/02/16
12/02
17:29
12/02/16
17:29
Syndicate
Breaking Syndicate news story on Moleculin Biotech »

Moleculin Biotech files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NEOG

Neogen

$61.59

-1.46 (-2.32%)

17:28
12/02/16
12/02
17:28
12/02/16
17:28
Hot Stocks
Neogen acquires U.K.-based Quat-Chem, terms undisclosed »

Neogen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRC

Range Resources

$36.36

-0.23 (-0.63%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Hot Stocks
Breaking Hot Stocks news story on Range Resources »

SailingStone Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EOG

EOG Resources

$103.74

-1.01 (-0.96%)

17:25
12/02/16
12/02
17:25
12/02/16
17:25
Syndicate
Breaking Syndicate news story on EOG Resources »

EOG Resources files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

, UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

17:22
12/02/16
12/02
17:22
12/02/16
17:22
Hot Stocks
Breaking Hot Stocks news story on HomeStreet, UMB Financial »

HomeStreet to replace UMB…

HMST

HomeStreet

$29.35

-0.2 (-0.68%)

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

, IM

Ingram Micro

$38.88

1.31 (3.49%)

17:21
12/02/16
12/02
17:21
12/02/16
17:21
Hot Stocks
UMB Financial to replace Ingram Micro in S&P 400 as of 12/6 close »

Tianjin Tianhai…

UMBF

UMB Financial

$77.00

-0.43 (-0.56%)

IM

Ingram Micro

$38.88

1.31 (3.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GMED

Globus Medical

$21.89

0.12 (0.55%)

, TLN

Talen Energy

17:20
12/02/16
12/02
17:20
12/02/16
17:20
Hot Stocks
Globus Medical to replace Talen Energy in S&P 400 as of 12/6 close »

Riverstone Holdings is…

GMED

Globus Medical

$21.89

0.12 (0.55%)

TLN

Talen Energy

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIXG

Aixtron

$3.97

-0.05 (-1.24%)

17:16
12/02/16
12/02
17:16
12/02/16
17:16
Periodicals
President Obama blocks China's takeover of Aixtron, CNBC reports »

Says the transaction…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$15.74

-0.32 (-1.99%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Periodicals
Deutsche Bank to pay $60M settlement over gold price-fixing case, Reuters says »

Deutsche Bank will pay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

ALB

Albemarle

$84.86

-0.79 (-0.92%)

17:07
12/02/16
12/02
17:07
12/02/16
17:07
Hot Stocks
Albemarle to increase prices for select brominated products »

Albemarle announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Mar

FOR

Forestar Group

$13.40

0.2 (1.52%)

17:06
12/02/16
12/02
17:06
12/02/16
17:06
Hot Stocks
Breaking Hot Stocks news story on Forestar Group »

Carlson Capital lowers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FANG

Diamondback Energy

$108.14

-1.86 (-1.69%)

17:04
12/02/16
12/02
17:04
12/02/16
17:04
Syndicate
Breaking Syndicate news story on Diamondback Energy »

Diamondback Energy files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSIR

Osiris

$5.68

0.06 (1.07%)

17:02
12/02/16
12/02
17:02
12/02/16
17:02
Hot Stocks
Osiris: Nasdaq grants company's request for additional time »

Osiris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STOR

STORE Capital

$24.45

0.52 (2.17%)

17:00
12/02/16
12/02
17:00
12/02/16
17:00
Hot Stocks
STORE Capital director Donovan acquires 4,350 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CARB

Carbonite

$17.95

0.25 (1.41%)

16:48
12/02/16
12/02
16:48
12/02/16
16:48
Hot Stocks
Breaking Hot Stocks news story on Carbonite »

Crosslink lowers stake in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GIB

CGI Group

$47.11

0.16 (0.34%)

16:48
12/02/16
12/02
16:48
12/02/16
16:48
Hot Stocks
CGI Group announces specific share repurchase program »

CGI Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.